{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,13]],"date-time":"2026-07-13T22:59:34Z","timestamp":1783983574625,"version":"3.55.0"},"reference-count":23,"publisher":"Elsevier BV","issue":"5","content-domain":{"domain":["nmcd-journal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Nutrition, Metabolism and Cardiovascular Diseases"],"published-print":{"date-parts":[[2014,5]]},"DOI":"10.1016\/j.numecd.2013.09.009","type":"journal-article","created":{"date-parts":[[2013,11,2]],"date-time":"2013-11-02T00:30:46Z","timestamp":1383352246000},"page":"476-482","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":29,"title":["Primary aldosteronism and essential hypertension: Assessment of cardiovascular risk at diagnosis and after treatment"],"prefix":"10.1016","volume":"24","author":[{"given":"F.","family":"Turchi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3100-076X","authenticated-orcid":false,"given":"V.","family":"Ronconi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"V.","family":"di Tizio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L.","family":"Ceccoli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Boscaro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G.","family":"Giacchetti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.numecd.2013.09.009_bib1","doi-asserted-by":"crossref","first-page":"3266","DOI":"10.1210\/jc.2008-0104","article-title":"2008 Case detection, diagnosis and treatment of patients with primary aldosteronism: an Endocrine Society Clinical Practice Guidelines","volume":"93","author":"Funder","year":"2008","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.numecd.2013.09.009_bib2","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1016\/j.tem.2008.01.006","article-title":"Primary aldosteronism: cardiovascular, renal and metabolic implications","volume":"19","author":"Rossi","year":"2008","journal-title":"Trends Endocrinol Metab"},{"issue":"8","key":"10.1016\/j.numecd.2013.09.009_bib3","doi-asserted-by":"crossref","first-page":"1243","DOI":"10.1016\/j.jacc.2005.01.015","article-title":"Evidence for an increased rate of cardiovascular events in patients with primary aldosteronism","volume":"45","author":"Milliez","year":"2005","journal-title":"J Am Coll Cardiol"},{"issue":"1","key":"10.1016\/j.numecd.2013.09.009_bib4","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1001\/archinternmed.2007.33","article-title":"Cardiovascular outcomes in patients with primary aldosteronism after treatment","volume":"168","author":"Catena","year":"2008","journal-title":"Arch Intern Med"},{"issue":"2","key":"10.1016\/j.numecd.2013.09.009_bib5","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1161\/HYPERTENSIONAHA.113.01060","article-title":"Cardiovascular complications associated with primary aldosteronism: a controlled cross-sectional study","volume":"62","author":"Savard","year":"2013","journal-title":"Hypertension"},{"key":"10.1016\/j.numecd.2013.09.009_bib6","doi-asserted-by":"crossref","first-page":"1125","DOI":"10.1210\/jc.2008-2116","article-title":"Cardiovascular and cerebrovascular comorbidities of hypokalemic and normokalemic primary aldosteronism: results of the German Conn's Registry","volume":"94","author":"Born-Frontsberg","year":"2009","journal-title":"J Clin Endocrinol Metab"},{"issue":"4","key":"10.1016\/j.numecd.2013.09.009_bib7","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1097\/01.hjh.0000217857.20241.0f","article-title":"Analysis of screening and confirmatory tests in the diagnosis of primary aldosteronism: need for a standardized protocol","volume":"24","author":"Giacchetti","year":"2006","journal-title":"J Hypertens"},{"key":"10.1016\/j.numecd.2013.09.009_bib8","first-page":"1105","article-title":"Guidelines Committee European Society of Hypertension-European Society of Cardiology guidelines for the management of arterial hypertension","volume":"25","year":"2007","journal-title":"J Hypertens"},{"issue":"Suppl. II","key":"10.1016\/j.numecd.2013.09.009_bib9","first-page":"II-19","article-title":"Detection of left ventricular hypertrophy by M-mode echocardiography: anatomic validation, standardization, and comparison to other methods","volume":"9","author":"Devereux","year":"1987","journal-title":"Hypertension"},{"key":"10.1016\/j.numecd.2013.09.009_bib10","doi-asserted-by":"crossref","first-page":"1471","DOI":"10.1161\/01.CIR.95.6.1471","article-title":"Remodeling of the left ventricle in primary aldosteronism due to Conn\u2019s adenoma","volume":"95","author":"Rossi","year":"1997","journal-title":"Circulation"},{"key":"10.1016\/j.numecd.2013.09.009_bib11","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1097\/HJH.0b013e3280108e6f","article-title":"Aldosterone as a key mediator of the cardiometabolic syndrome in primary aldosteronism: an observational study","volume":"25","author":"Giacchetti","year":"2007","journal-title":"J Hypertens"},{"key":"10.1016\/j.numecd.2013.09.009_bib12","doi-asserted-by":"crossref","first-page":"3457","DOI":"10.1210\/jc.2006-0736","article-title":"Insulin sensitivity in patients with primary aldosteronism: a follow up study","volume":"91","author":"Catena","year":"2006","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.numecd.2013.09.009_bib13","doi-asserted-by":"crossref","first-page":"454","DOI":"10.1210\/jc.2005-1733","article-title":"Prevalence and characteristics of the metabolic syndrome in primary aldosteronism","volume":"91","author":"Fallo","year":"2006","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.numecd.2013.09.009_bib14","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/j.numecd.2009.03.007","article-title":"Metabolic syndrome in primary aldosteronism and essential hypertension: relationship to adiponectin gene variants","volume":"20","author":"Ronconi","year":"2010","journal-title":"Nutr Metab Cardiovasc Dis"},{"key":"10.1016\/j.numecd.2013.09.009_bib15","doi-asserted-by":"crossref","first-page":"855","DOI":"10.1016\/j.amjhyper.2007.03.012","article-title":"Adiponectin and insulin sensitivity in primary aldosteronism","volume":"20","author":"Fallo","year":"2007","journal-title":"Am J Hypertens"},{"key":"10.1016\/j.numecd.2013.09.009_bib16","doi-asserted-by":"crossref","first-page":"911","DOI":"10.1161\/HYPERTENSIONAHA.107.095448","article-title":"Long-term cardiac effects of adrenalectomy or mineralocorticoid antagonist in patients with primary aldosteronism","volume":"50","author":"Catena","year":"2007","journal-title":"Hypertension"},{"key":"10.1016\/j.numecd.2013.09.009_bib17","doi-asserted-by":"crossref","first-page":"1039","DOI":"10.1161\/01.HYP.27.5.1039","article-title":"Changes in left ventricular anatomy and function in hypertension and primary aldosteronism","volume":"27","author":"Rossi","year":"1996","journal-title":"Hypertension"},{"key":"10.1016\/j.numecd.2013.09.009_bib18","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1161\/01.HYP.0000023182.68420.EB","article-title":"Excess aldosterone is associated with alteration of myocardial texture in primary aldosteronism","volume":"40","author":"Rossi","year":"2002","journal-title":"Hypertension"},{"key":"10.1016\/j.numecd.2013.09.009_bib19","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1161\/HYPERTENSIONAHA.108.114140","article-title":"Inappropriate left ventricular mass in patients with primary aldosteronism","volume":"52","author":"Muiesan","year":"2008","journal-title":"Hypertension"},{"issue":"1","key":"10.1016\/j.numecd.2013.09.009_bib20","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1161\/HYPERTENSIONAHA.113.01316","article-title":"Long-term control of arterial hypertension and regression of left ventricular hypertrophy with treatment of primary aldosteronism","volume":"62","author":"Rossi","year":"2013","journal-title":"Hypertension"},{"issue":"3","key":"10.1016\/j.numecd.2013.09.009_bib21","first-page":"274","article-title":"Cardiovascular changes in patients with primary aldosteronism after surgical or medical treatment","volume":"35","author":"Bernini","year":"2012","journal-title":"J Endocrinol Invest"},{"key":"10.1016\/j.numecd.2013.09.009_bib22","first-page":"21","article-title":"Insulin action in primary aldosteronism before and after surgical or pharmacological treatment","volume":"108","author":"Sindelka","year":"2000","journal-title":"Exp Clin Endocrinol Diabetes"},{"key":"10.1016\/j.numecd.2013.09.009_bib23","first-page":"755","article-title":"Does insulin resistance participate in an impaired glucose tolerance in primary aldosteronism?","volume":"10","author":"Shimamoto","year":"1994","journal-title":"J Hum Hypertens"}],"container-title":["Nutrition, Metabolism and Cardiovascular Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0939475313002573?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0939475313002573?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,10,10]],"date-time":"2018-10-10T22:54:38Z","timestamp":1539212078000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0939475313002573"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,5]]},"references-count":23,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2014,5]]}},"alternative-id":["S0939475313002573"],"URL":"https:\/\/doi.org\/10.1016\/j.numecd.2013.09.009","relation":{},"ISSN":["0939-4753"],"issn-type":[{"value":"0939-4753","type":"print"}],"subject":[],"published":{"date-parts":[[2014,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Primary aldosteronism and essential hypertension: Assessment of cardiovascular risk at diagnosis and after treatment","name":"articletitle","label":"Article Title"},{"value":"Nutrition, Metabolism and Cardiovascular Diseases","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.numecd.2013.09.009","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2013 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}